is retatrutide better than semaglutide Vs Tirzepatide Vs Retatrutide vs. semaglutide: A head-to-head

If everything goes as planned, it may be approved by the FDA in 2026 or later

FDA pharmacovigilance data shows burping has the highest reporting odds ratio of any GI side effect at 42.03

There is also growing interest in whether GLP-1 medications may help with nicotine dependence, binge eating disorder, and other compulsive reward-driven behaviors, says Anton

Loos, a professor at the University of Copenhagen and affiliated with a research center supported by the Novo Nordisk Foundation (the maker of Wegovy and Ozempic), noted, "The current model explains only 25% of the variability, and further research is needed to uncover the remaining 75%." However, she also expressed optimism, stating, "By combining genetic and clinical information, the era of personalized medicine, where we can select the best drug for each patient, may be upon us."